These findings reinforce the idea that IL-6 trans-signalling could play a role in the severity of COVID-19 and IL-6 trans-signalling related variables could be biomarkers in the progression of the disease rather than the levels of IL-6. This evidence concerns the gene IL6 and COVID-19.